Summary by Moomoo AI
Agape ATP Corporation has entered into a strategic collaboration with Formedic Technologies on September 25, 2024, to introduce LEGA, an electronic chest percussion device for respiratory care. The device, which has already been deployed in approximately 2,000 units across major hospitals globally, aids patients with COPD, pneumonia, and bronchiectasis in both hospital and home care settings.The partnership targets the expanding respiratory care market, projected to reach $25.95B in 2024 and grow to $49.84B by 2031. This collaboration enables ATPC to diversify its wellness portfolio while leveraging Formedic's healthcare technology expertise and R&D capabilities. The initiative aligns with ATPC's strategy to build a comprehensive wellness ecosystem encompassing both preventive and curative solutions.The companies will jointly develop marketing strategies to establish LEGA as a leading respiratory care solution, focusing on expanding its accessibility to hospitals, rehabilitation centers, and home users globally. The partnership also emphasizes ongoing R&D efforts to advance respiratory care innovations and improve patient outcomes.
